MANAMA (Reuters) - The Trump administration launched a $50 billion economic formula for Israeli-Palestinian peace on Tuesday, saying an investment program for the Palestinians was a precondition for ending the decades-old conflict.

NEW YORK, June 25 (Reuters) - Gold soared to an almost six-year high on Tuesday on escalating U.S.-Iran tensions, while equity markets slid on disappointing economic data and uncertainty that the Federal Reserve will cut interest rates in July as has been expected.

GUATEMALA CITY, June 25 (Reuters) - The U.S. Department of Homeland Security will deploy up to 89 agents to Guatemala by the end of August under a joint agreement to curb illegal immigration and strengthen border security, according to an official document seen by Reuters on Tuesday.

WASHINGTON (Reuters) - Stephanie Grisham, communications director for first lady Melania Trump and a longtime aide to President Donald Trump, will succeed Sarah Sanders as White House press secretary, Mrs. Trump announced on Tuesday.

WASHINGTON (Reuters) - A federal judge on Tuesday refused to put on hold a lawsuit by about 200 Democratic lawmakers accusing President Donald Trump of violating an anti-corruption provision of the U.S. Constitution with his private business dealings, a move that clears the way for them to seek some of his financial records.

WASHINGTON, June 25 (Reuters) - Acting U.S. Defense Secretary Mark Esper said on Tuesday he aimed to recruit support from NATO allies for U.S. efforts to deter conflict with Iran and "open the door to diplomacy," as he made his international debut as Pentagon chief.

(This June 24 story, corrects title of Simon Sim to president of the U.S. arm of Netmarble Corp instead of president of the South Korean mobile gaming company, paragraph 5.)

LOS ANGELES, June 24 (Reuters) - K-Pop stars BTS have conquered the charts with their music and the box office with documentary "Burn the Stage: The Movie," and now they're aiming for mobile phones with the game BTS World.

(Reuters) - Drugmaker AbbVie Inc said on Tuesday it would acquire Allergan Plc for about $63 billion, giving AbbVie control over the lucrative wrinkle treatment Botox and buying time to seek new growth before its blockbuster arthritis treatment Humira loses U.S. patent protection.